Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07134075
PHASE2

Intracochlear Injection of Glucocorticoid

Sponsor: Eye & ENT Hospital of Fudan University

View on ClinicalTrials.gov

Summary

This study is a prospective, randomized pilot study. To verify safety and efficacy of intracochlear injection of glucocorticoid through the round window membrane in patients with total sudden sensorineural hearing loss safety and efficacy in total sudden sensorineural hearing loss patients as an early salvage therapy.

Official title: Safety and Efficacy of Intracochlear Injection of Glucocorticoid Through the Round Window Membrane in Patients With Total Sudden Sensorineural Hearing Loss

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-08-25

Completion Date

2027-08-01

Last Updated

2025-08-21

Healthy Volunteers

No

Interventions

DRUG

intracochlear triamcinolone acetonide injection

intracochlear triamcinolone acetonide injection of through the round window membrane

DRUG

intracochlear injection of dexamethasone through the round window membrane

intracochlear injection of dexamethasone sodium phosphate through the round window membrane

DRUG

intracochlear dexamethasone injection and intratympanic dexamethasone injection

intracochlear dexamethasone sodium phosphate injection of through the round window membrane, intratympanic dexamethasone sodium phosphate injection through the tympanic membrane

DRUG

intratympanic dexamethasone injection

intratympanic dexamethasone sodium phosphate injection (10mg/ml) through tympanic membrane,once every other day, for a total of 4 injections.

Locations (1)

Fenyang Road 83

Shanghai, Shanghai Municipality, China